Total Payments
$220,875
2024 Payments
$62,099
Companies
30
Transactions
1,043
Medicare Patients
2,099
Medicare Billing
$247,349
Payment Breakdown by Category
Other$169,549 (76.8%)
Food & Beverage$26,839 (12.2%)
Consulting$15,260 (6.9%)
Travel$8,724 (3.9%)
Education$502.96 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $169,549 | 81 | 76.8% |
| Food and Beverage | $26,839 | 867 | 12.2% |
| Consulting Fee | $15,260 | 9 | 6.9% |
| Travel and Lodging | $8,724 | 73 | 3.9% |
| Education | $502.96 | 13 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $120,155 | 474 | $0 (2024) |
| ViiV Healthcare Company | $91,108 | 244 | $0 (2024) |
| ABBVIE INC. | $1,399 | 45 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,367 | 79 | $0 (2024) |
| Janssen Biotech, Inc. | $1,359 | 63 | $0 (2023) |
| Janssen Products, LP | $885.95 | 10 | $0 (2021) |
| Insmed, Inc. | $762.37 | 24 | $0 (2024) |
| Adaptive Biotechnologies Corporation | $756.59 | 3 | $0 (2020) |
| Theratechnologies Inc. | $604.26 | 21 | $0 (2024) |
| COMSORT, Inc | $350.00 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62,099 | 134 | ViiV Healthcare Company ($42,171) |
| 2023 | $56,530 | 126 | ViiV Healthcare Company ($42,055) |
| 2022 | $11,341 | 120 | Gilead Sciences, Inc. ($9,711) |
| 2021 | $14,538 | 151 | Gilead Sciences, Inc. ($9,027) |
| 2020 | $10,363 | 101 | Gilead Sciences, Inc. ($8,655) |
| 2019 | $32,690 | 175 | Gilead Sciences, Inc. ($30,742) |
| 2018 | $16,349 | 111 | Gilead Sciences, Inc. ($14,159) |
| 2017 | $16,965 | 125 | Gilead Sciences Inc ($15,059) |
All Payment Transactions
1,043 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.57 | General |
| 12/19/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: HIV | ||||||
| 12/12/2024 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $67.08 | General |
| Category: HIV | ||||||
| 12/11/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/03/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: HIV | ||||||
| 12/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.33 | General |
| 11/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: HIV | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $2.70 | General |
| 11/21/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: HIV | ||||||
| 11/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.88 | General |
| 11/08/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,925.00 | General |
| Category: HIV | ||||||
| 11/08/2024 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $67.08 | General |
| Category: HIV | ||||||
| 11/07/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: HIV | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/25/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,150.00 | General |
| Category: HIV | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $131.63 | General |
| 10/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.39 | General |
| 10/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.15 | General |
| 10/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: VIROLOGY | ||||||
| 10/10/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: HIV | ||||||
| 10/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $2.48 | General |
| 10/02/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 582 | 721 | $217,855 | $67,477 |
| 2022 | 13 | 556 | 683 | $208,946 | $65,453 |
| 2021 | 12 | 562 | 704 | $215,382 | $69,492 |
| 2020 | 11 | 399 | 534 | $151,647 | $44,927 |
Total Patients
2,099
Total Services
2,642
Medicare Billing
$247,349
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 160 | 227 | $45,173 | $14,770 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 138 | $41,952 | $13,179 | 31.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 53 | $29,733 | $7,620 | 25.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 60 | $22,860 | $6,597 | 28.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $17,949 | $5,730 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $14,446 | $4,166 | 28.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 37 | $10,582 | $3,805 | 36.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 21 | $9,744 | $3,535 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 45 | $9,270 | $3,207 | 34.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 26 | $10,530 | $2,743 | 26.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 44 | 52 | $5,616 | $2,126 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 137 | $41,648 | $12,106 | 29.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 115 | 172 | $34,228 | $10,740 | 31.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 54 | $30,294 | $9,234 | 30.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 44 | 44 | $25,476 | $8,809 | 34.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 73 | 74 | $28,194 | $8,558 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $11,650 | $3,690 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 26 | $10,530 | $3,168 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 38 | $7,828 | $2,673 | 34.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 23 | $6,578 | $2,076 | 31.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 11 | $5,104 | $1,903 | 37.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 47 | 55 | $5,940 | $1,839 | 31.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $876.00 | $415.80 | 47.5% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 12 | 12 | $600.00 | $240.84 | 40.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 156 | $47,424 | $14,697 | 31.0% |
About Phuong Trinh
Phuong Trinh is a Infectious Disease healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679536486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Phuong Trinh has received a total of $220,875 in payments from pharmaceutical and medical device companies, with $62,099 received in 2024. These payments were reported across 1,043 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($169,549).
As a Medicare-enrolled provider, Trinh has provided services to 2,099 Medicare beneficiaries, totaling 2,642 services with total Medicare billing of $247,349. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Silver Spring, MD
- Active Since 04/11/2006
- Last Updated 02/21/2013
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1679536486
Products in Payments
- DOVATO (Drug) $81,993
- Biktarvy (Drug) $65,837
- CABENUVA (Biological) $5,113
- Genvoya (Drug) $4,423
- Sunlenca (Drug) $3,736
- Odefsey (Drug) $1,606
- TRIUMEQ (Drug) $851.70
- Arikayce (Drug) $762.37
- clonoSEQ (Device) $756.59
- Symtuza (Drug) $700.84
- AVYCAZ (Drug) $609.38
- SYMTUZA (Drug) $598.05
- JULUCA (Drug) $576.46
- APRETUDE (Biological) $560.86
- PREZCOBIX (Drug) $554.79
- ZERBAXA (Drug) $423.62
- MAVYRET (Drug) $387.39
- DIFICID (Drug) $357.28
- ISENTRESS (Drug) $319.82
- RUKOBIA (Drug) $312.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Silver Spring
Michael Koren, M.d, M.D
Infectious Disease — Payments: $106,100
Infectious Disease $106,100
Dr. Lynette Posorske, Md, MD
Infectious Disease — Payments: $79,479
Infectious Disease $79,479
Barbara Matthews, Md, Mph, MD, MPH
Infectious Disease — Payments: $36,685
Infectious Disease $36,685
Mrs. Rebecca Shaffer, Md, MD
Infectious Disease — Payments: $9,143
Infectious Disease $9,143
Vasilios Pyrgos, Md, MD
Infectious Disease — Payments: $7,622
Infectious Disease $7,622
Dr. John Mcneil, M.d, M.D
Infectious Disease — Payments: $1,655
Infectious Disease $1,655